Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.